Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-30

Clinical Trial Update: Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation [Phase 4]

View source ↗

Summary

Phase 4 trial investigating liraglutide effects on liver glucose phosphorylation, status withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liraglutide (liraglutide)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Type 2 Diabetes | Phase 4 | Status: WITHDRAWN